Article
Birt-Hogg-Dubé syndrome: from gene discovery to molecularly targeted therapies.
Familial cancer - 1 Sept 2013
Schmidt Laura S
Abstract excerpt
Since the hallmark dermatologic features of Birt-Hogg-Dubé (BHD) syndrome were first described by three Canadian physicians in 1977, the clinical manifestations of BHD have been expanded to include hamartomas of the hair follicle, lung cysts, increased risk for spontaneous pneumothorax and kidney neoplasia. Twenty-five years later the causative gene FLCN was identified, and the mutation spectrum has now been...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
